spacer
spacer

PDBsum entry 3dpy

Go to PDB code: 
protein ligands metals Protein-protein interface(s) links
Transferase PDB id
3dpy

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
323 a.a. *
407 a.a. *
Ligands
VAL-ILE-MET
FPP
ACY
Metals
_ZN
Waters ×60
* Residue conservation analysis
PDB id:
3dpy
Name: Transferase
Title: Protein farnesyltransferase complexed with fpp and caged tkcvim substrate
Structure: Protein farnesyltransferase/geranylgeranyltransferase type- 1 subunit alpha. Chain: a. Synonym: caax farnesyltransferase subunit alpha, ras proteins prenyltransferase alpha, ftase-alpha, type i protein geranyl- geranyltransferase subunit alpha, ggtase-i-alpha. Engineered: yes. Protein farnesyltransferase subunit beta. Chain: b.
Source: Rattus norvegicus. Brown rat,rat,rats. Organism_taxid: 10116. Gene: fnta. Expressed in: spodoptera frugiperda. Expression_system_taxid: 7108. Gene: fntb. Synthetic: yes. Other_details: synthesized peptide
Resolution:
2.70Å     R-factor:   0.217     R-free:   0.253
Authors: M.A.Hast,L.S.Beese
Key ref: A.J.DeGraw et al. (2008). Caged protein prenyltransferase substrates: tools for understanding protein prenylation. Chem Biol Drug Des, 72, 171-181. PubMed id: 18844669
Date:
09-Jul-08     Release date:   30-Sep-08    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
Q04631  (FNTA_RAT) -  Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha from Rattus norvegicus
Seq:
Struc:
377 a.a.
323 a.a.
Protein chain
Pfam   ArchSchema ?
Q02293  (FNTB_RAT) -  Protein farnesyltransferase subunit beta from Rattus norvegicus
Seq:
Struc:
437 a.a.
407 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 Enzyme reactions 
   Enzyme class 1: Chains A, B: E.C.2.5.1.58  - protein farnesyltransferase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: L-cysteinyl-[protein] + (2E,6E)-farnesyl diphosphate = S-(2E,6E)- farnesyl-L-cysteinyl-[protein] + diphosphate
L-cysteinyl-[protein]
Bound ligand (Het Group name = FPP)
corresponds exactly
+ (2E,6E)-farnesyl diphosphate
= S-(2E,6E)- farnesyl-L-cysteinyl-[protein]
+ diphosphate
      Cofactor: Mg(2+); Zn(2+)
   Enzyme class 2: Chain A: E.C.2.5.1.59  - protein geranylgeranyltransferase type I.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: geranylgeranyl diphosphate + L-cysteinyl-[protein] = S-geranylgeranyl-L- cysteinyl-[protein] + diphosphate
geranylgeranyl diphosphate
Bound ligand (Het Group name = FPP)
matches with 82.76% similarity
+ L-cysteinyl-[protein]
= S-geranylgeranyl-L- cysteinyl-[protein]
+ diphosphate
      Cofactor: Zn(2+)
Note, where more than one E.C. class is given (as above), each may correspond to a different protein domain or, in the case of polyprotein precursors, to a different mature protein.
Molecule diagrams generated from .mol files obtained from the KEGG ftp site

 

 
    reference    
 
 
Chem Biol Drug Des 72:171-181 (2008)
PubMed id: 18844669  
 
 
Caged protein prenyltransferase substrates: tools for understanding protein prenylation.
A.J.DeGraw, M.A.Hast, J.Xu, D.Mullen, L.S.Beese, G.Barany, M.D.Distefano.
 
  ABSTRACT  
 
Originally designed to block the prenylation of oncogenic Ras, inhibitors of protein farnesyltransferase currently in preclinical and clinical trials are showing efficacy in cancers with normal Ras. Blocking protein prenylation has also shown promise in the treatment of malaria, Chagas disease and progeria syndrome. A better understanding of the mechanism, targets and in vivo consequences of protein prenylation are needed to elucidate the mode of action of current PFTase (Protein Farnesyltransferase) inhibitors and to create more potent and selective compounds. Caged enzyme substrates are useful tools for understanding enzyme mechanism and biological function. Reported here is the synthesis and characterization of caged substrates of PFTase. The caged isoprenoid diphosphates are poor substrates prior to photolysis. The caged CAAX peptide is a true catalytically caged substrate of PFTase in that it is to not a substrate, yet is able to bind to the enzyme as established by inhibition studies and X-ray crystallography. Irradiation of the caged molecules with 350 nm light readily releases their cognate substrate and their photolysis products are benign. These properties highlight the utility of those analogs towards a variety of in vitro and in vivo applications.
 

Literature references that cite this PDB file's key reference

  PubMed id Reference
20180535 A.J.DeGraw, M.J.Keiser, J.D.Ochocki, B.K.Shoichet, and M.D.Distefano (2010).
Prediction and evaluation of protein farnesyltransferase inhibition by commercial drugs.
  J Med Chem, 53, 2464-2471.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time.

 

spacer

spacer